LENSAR, Inc.
NASDAQ:LNSRMedical - Devices
-$0.51 today
- Market cap
- $59.63M
- Beta
- 0.87
- P/E (TTM)
- 2.4
- EPS (TTM)
- $2.42
Volume 0.06M
Average 0.09M
LNSR Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
LENSAR, Inc.NASDAQ: LNSR
Accounts Payables · Q1 FY2026 · quarter ended Mar 2026
Accounts payables turns negative
Q1 FY2026 accounts payables was -$3.89M, compared with $1.76M a year earlier. Trailing-twelve-month accounts payables was $7.34M. Over 3 fiscal years it compounded at +68.2% a year.
Context
- Accounts payables amounted to 22.2% of revenue in FY2025, up 18.6 pp from a year earlier.
- Accounts payables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly accounts payables holds near -$3.89M or moves back toward the trailing-twelve-month quarterly average of $1.84M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- 12.99M USD
- Year-over-year change
- +564.0%
- 4-year CAGR
- +179.4%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 12.99M | +564.0% |
| FY2024 | 2024-12-31 | 1.96M | +238.0% |
| FY2023 | 2023-12-31 | (1.42M) | -151.9% |
| FY2022 | 2022-12-31 | 2.73M | +1181.2% |
| FY2021 | 2021-12-31 | 213K | — |
Accounts Payables vs competitors
How LNSR compares with its peers on the latest reported figures
- LNSR's LTM Mar 2026 accounts payables of $7.34M is the largest of the 10 companies compared; the peer median is $887K.
- Its year-over-year change of +97.9% is the 4th highest of 10, against a peer median of +38.0%.
- Accounts payables amounts to 12.7% of revenue for LNSR, versus a peer median of 5.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $7.34M | +97.9% | +68.2% | 12.7% | |
| LTM Mar 2026 | $5.21M | +1496.2% | +17.8% | 992.0% | |
| LTM Mar 2026 | $3.53M | -272.3% | +109.1% | — | |
| LTM Mar 2026 | $2.37M | +45.7% | -27.2% | 5.3% | |
| LTM Mar 2026 | $2.03M | +38.0% | +2.5% | 5.9% | |
| LTM Mar 2026 | $1.77M | -57.7% | +191.8% | 5.5% | |
| LTM Mar 2026 | $951K | -76.2% | — | 0.9% | |
AVRAnteris Technologies Global Corp. | LTM Mar 2026 | $887K | +2749.0% | — | 47.9% |
| LTM Mar 2026 | $740K | +125.9% | -72.2% | 0.6% | |
| LTM Mar 2026 | $387.3K | -77.1% | — | 2.1% | |
| Peer median (excluding LNSR) | $887K | +38.0% | +10.2% | 5.4% | |
Competitors are the stored peer set for LNSR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (19.6M) | (19.91M) | (14.38M) | (31.4M) | (34.28M) |
| Depreciation & Amortization | 2.76M | 3.41M | 3.52M | 3.93M | 4.5M |
| Deferred Income Tax | 527K | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 6.87M | 6.61M | 5.54M | 2.67M | 3.14M |
| Change in Working Capital | (42K) | (5.58M) | (7.78M) | (3.04M) | 1.1M |
| Accounts Receivables | (2.65M) | (1.44M) | 1.08M | (2.1M) | 289K |
| Inventory | 2.33M | (6.89M) | (7.46M) | (4.9M) | (13.9M) |
| Accounts Payables | 213K | 2.73M | (1.42M) | 1.96M | 12.99M |
| Other Working Capital | 66K | 23K | 23K | 2M | 1.72M |
| Other Non-Cash Items | 517K | 618K | 3.45M | 25.58M | 10.7M |
| Operating Cash Flow | (8.97M) | (14.86M) | (9.66M) | (2.28M) | (14.83M) |
| Capital Expenditures | (354K) | (115K) | (236K) | (156K) | (83K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | (3.92M) | (10.25M) | (11.88M) |
| Sales of Investments | 0 | 0 | 0 | 8.24M | 13.25M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (354K) | (115K) | (4.16M) | (2.16M) | 1.28M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 361K | 408K | 0 | 58K | 258K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (2.4M) | 5.88M | 20K | 10M |
| Financing Cash Flow | 361K | (1.99M) | 19.76M | 78K | 10.26M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (8.96M) | (16.96M) | 5.95M | (4.36M) | (3.29M) |
| Free Cash Flow | (9.32M) | (14.97M) | (9.9M) | (2.43M) | (14.91M) |
LENSAR, Inc.
NASDAQ:LNSR
Intrinsic Alpha fair value
Locked
Current Price
$4.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.